Page last updated: 2024-11-07

spironolactone and Opportunistic Infections

spironolactone has been researched along with Opportunistic Infections in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oosterhuis, JK1
van den Berg, G1
Monteban-Kooistra, WE1
Ligtenberg, JJ1
Tulleken, JE1
Meertens, JH1
Zijlstra, JG1

Other Studies

1 other study available for spironolactone and Opportunistic Infections

ArticleYear
Life-threatening Pneumocystis jiroveci pneumonia following treatment of severe Cushing's syndrome.
    The Netherlands journal of medicine, 2007, Volume: 65, Issue:6

    Topics: Cushing Syndrome; Disease Progression; Fatal Outcome; Female; Humans; Ketoconazole; Middle Aged; Mif

2007